Qi Rui Yang, MD
Sleep Medicine · Rochester, NYNPI 1851488860
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Fisher & Paykel Healthcare Inc at 28.0% of the total. Reporting peaked in 2023 at $262 and has fallen 90.1% since, to $26 in 2025. That places this record below the midpoint for sleep medicine clinicians in NY, where the typical reported total is $1,050.
Across 24 payments — averaging $29.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fisher & Paykel Healthcare Inc$200
- Jazz Pharmaceuticals Inc.$161
- Eisai Inc.$125
- Inspire Medical Systems, Inc.$43
- Harmony Biosciences LLC$43
- Axsome Therapeutics, Inc.$42
- plus $100 from 4 others
What the payments were for
- Food & beverage$714100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fisher & Paykel Healthcare Inc | 7 | $200 |
| Jazz Pharmaceuticals Inc. | 6 | $161 |
| Eisai Inc. | 1 | $125 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| Harmony Biosciences LLC | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Merck | 1 | $35 |
| Si-bone, Inc. | 1 | $30 |
| Boehringer Ingelheim | 1 | $20 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $15 |
How this compares
$714 in reported general payments places this provider in the 40th percentile of 81 sleep medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Modafinil | 23 | $2,225 |
| Armodafinil | 20 | $898 |
| Ropinirole Hcl | 15 | $143 |
| Clonazepam | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Rochester
- Michael CohenRochester$4K
- Edward KayeRochester$4K
- Michael YurcheshenRochester$3K
- Margarita ZhavoronkovaRochester$557
- David RapoportNew York$313K
- Ofer JacobowitzNew York$141K
- Qanta AhmedMineola$83K
- Andrew WestwoodNew York$82K
- Omar BurschtinNew York$71K
- Maha AhmadNew York$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.